Published • loading... • Updated
Obesity Drug Semaglutide Fails to Slow Alzheimer's
Summary by BBC News
5 Articles
5 Articles
Novo Nordisk shares slide after Ozempic pill fails in Alzheimer’s trials
Report dashes hopes for new use for blockbuster weight-loss drugBusiness live – latest updatesNovo Nordisk shares slumped on Monday after the drugmaker said the pill version of its weight-loss drug Ozempic had failed to slow the progression of Alzheimer’s disease in two large studies.The Danish company said patients who took the drug did not see their disease progress more slowly, dashing hopes for a new use for the blockbuster diabetes drug. Co…
Coverage Details
Total News Sources5
Leaning Left2Leaning Right0Center3Last UpdatedBias Distribution60% Center
Bias Distribution
- 60% of the sources are Center
60% Center
L 40%
C 60%
Factuality
To view factuality data please Upgrade to Premium

